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Oxidativestressisamechanismunderlyingdiﬀerentkindsofinfertilityinhumanmales.However,diﬀerentresultscanbeobserved
in relation to the method used for its evaluation. Varicocele patients show a number of biochemical abnormalities, including
an altered distribution of coenzyme Q between seminal plasma and sperm cells and also an apparent defect in the utilization
of antioxidants. Moreover, an inﬂuence of systemic hormones on seminal antioxidant system was observed too. Finally, the
eﬀects of surgical treatment on oxidativestress indexes and the possible usefulness of some medical therapies, like coenzyme Q
supplementation, are discussed. In conclusion, published data show a role of oxidative stress in varicocele-related male infertility,
but at present we do not know the precise molecular mechanisms underlying these phenomena.
1. OxidativeStress in Male Infertility
An excess of reactive oxygen species (ROS) and other
oxidant radicals, in the body but in particular at genital
level, has been associated with male infertility [1–5]. The
high content of polyunsaturated fatty acids within the
spermatozoa plasma membrane and the low concentration
of cytoplasmic scavenging enzymes make these cells highly
susceptible to peroxidation in the presence of high levels of
ROS in seminal ﬂuid [6–8]. It has been shown that the time
of permanence of spermatozoa in the epididymis is longer
in oligozoospermic patients, resulting in a higher exposure
to ROS [9–11]. The source of ROS in seminal ﬂuid is due to
bothspermcellsandinﬁltratingleukocytes[12].Thereisalso
a correlation between leukocyte concentrations, ROS levels,
lipid peroxidation, and functional damage [13].
To counteract the potentially damaging eﬀects of oxida-
tive stress (OS), sperm cells and seminal plasma are endowed
with some protective antioxidant systems. Spermatozoa
have a rather low level of enzymatic antioxidant defence,
including catalase, superoxide dismutase (SOD), and glu-
tathione peroxidise. On the contrary, seminal plasma is well
endowed with antioxidant buﬀer capacity [14]. The role of
ascorbicacidanduricacid,amongthelow-molecular-weight
antioxidants in seminal plasma, has also been highlighted
[14].
Studies in infertile men have shown an impaired sem-
inal plasma nonenzymatic antioxidant capacity [15]. The
total oxyradical scavenging capacity (TOSC) is a recently
developedassaymeasuringtheoverallcapabilityofbiological
ﬂuids or cellular antioxidants to neutralize the toxicity
of various oxyradicals [16, 17]. The TOSC assay can
discriminate between diﬀerent forms of ROS, allowing to
identify the role of speciﬁc antioxidants in the onset of
pathological processes. An early application of the TOSC
assay in andrology showed a reduced antioxidant eﬃciency
in seminal ﬂuid of infertile men with a signiﬁcant corre-
lation between the scavenging capacity of hydroxyl radicals
and the parameters of sperm cell motility [18]. Another
simpler method to measure the total antioxidant system2 Advances in Urology
(TAOS), also called total antioxidant capacity (TAC), was
conceived by Rice-Evans and Miller [19]. In this method,
the system metmyoglobin-H2O2 is used as source of radicals,
which interaction with the chromogen 2,2I-azinobis-3-
ethylbenzothiazoline-6-sulphonate (ABTS) generates a radi-
cal cation which is spectroscopically detectable. Antioxidants
contrast this reaction, so that the lag time in the formation of
ABTS
+◦ is proportional to the antioxidant content. In a 2003
study, for the ﬁrst time we applied this method, with minor
modiﬁcations, to seminal plasma from varicocele infertile
patients [20].
2.StudieswithVaricocelePatients
Varicocele (VAR) is a model of male infertility particularly
interesting, from the andrological point of view, not only
for its prevalence (19–41% of infertile men) [21] but also
in relation to an open debate on the real need of surgical
or sclerotherapic treatment and on its role in causing
infertility. Furthermore, diﬀerent studies suggest that OS
is a common mechanism underlying VAR, as well as X-
irradiation, exposure to environmental toxicants, or other
physical conditions such as cryptorchidism. All these stress
conditions can cause changes in testicular microvascular
blood ﬂow and endocrine signalling, eventually leading to
germ cell apoptosis and hypospermatogenesis [22].
Other studies suggest that VAR patients have high OS
also in the case of normozoospermia. DNA fragmenta-
tion index (the percentage of sperm cells with denatured
DNA), determined by ﬂow cytometry, and the percentage
of TUNEL-positive cells, another estimate of sperm DNA
damage, have been found signiﬁcantly greater in VAR, either
with normal or abnormal semen proﬁle, than in control
fertile subjects. Likewise, ROS levels were signiﬁcantly higher
in both sub-groups of VAR patients [23]. Sakamoto and
colleagues showed a signiﬁcantly higher hexanoyl-l-lysine
(HEL) concentration and SOD activity in seminal plasma
in azoospermic and oligozoospermic patients; those with
VAR had a signiﬁcantly higher NO, HEL, and SOD activity
in plasma. Oligozoospermic patients with VAR presented
signiﬁcantly higher IL-6 in seminal plasma. After varic-
ocelectomy, a signiﬁcant increase in sperm concentration
was found together with a reduction in NO, HEL, 8-
Hydroxydeoxyguanosine(8-OHdG)levels,andSODactivity,
a reduction in IL-6, and a decrease in the percentage of
apoptosis-positive sperm, evaluated by sperm DNA frag-
mentation [24].
A prospective study, before and after varicocelectomy,
was also performed in subfertile patients. The parameters
for evaluating OS changes were (a) 4977bp deletion of
mitochondrial DNA in sperm, as detected by PCR, (b) 8-
OHdG content in spermatozoa DNA, measured by HPLC
electrochemical method, (c) seminal plasma protein thiols
and ascorbic acid. Varicocelectomy had a positive eﬀect
on seminal parameters in 22/30 patients, with a decrease
in 4977bp deletion of mitochondrial DNA and 8-OHdG
levels, and an increase in plasma thiols and ascorbic acid.
Interestingly, also in eight patients in whom semen quality
did not improve after surgery, a signiﬁcant decrease in 8-
OHdG in sperm DNA and an increase in thiols and ascorbic
acid were observed [25].
A standardized semen quality score, proposed by
Pasqualotto and colleagues, applying principal component
analysis to nine semen characteristics, did not show dif-
ferences between infertile and fertile subjects with VAR;
however, the mean quality score was lower than that in
healthy controls. Moreover, the authors showed signiﬁcant
lower ROS-TAC scores in infertile males compared with
control subjects, but the scores of non-VAR fertile subjects
werenotsigniﬁcantlydiﬀerentfromthoseoffertilemenwith
VAR [26]. Therefore, it can be reasonably hypothesized that
the fertility potential in VAR can decline due to OS.
A meta-analysis has been published, collecting 23 human
studies on the topic of OS in VAR-associated infertility [27],
Four studies of these were selected for the similar methods
of measuring ROS. The overall estimate showed higher
concentrations of ROS and lower total antioxidant capacity
inVARthanincontrols.InthementionedpaperbyMeucciet
al. [20], we showed a Lag value (TAC) signiﬁcantly greater in
VARpatientsthaninnon-VAR.Butitshouldberemembered
that measuring TAC is diﬀerent from measuring ROS.
Oligospermic VAR patients showed the greatest values of
TAC. Lag and sperm motility signiﬁcantly correlated in VAR
normospermicpatients.Follicle-stimulatinghormone(FSH)
showed signiﬁcant inverse association with Lag in the same
group. This partially unexpected results was interpreted as
an ineﬀective utilization of antioxidants in oligospermic
VAR, while in normozoospermic VAR the direct correlation
between TAC and motility suggested a protective role
toward sperm motility. Finally, in the same subgroup, the
inverse correlation with FSH suggested a better utilization
of antioxidants thanks to the increasing FSH levels, with a
compensation with still unknown mechanisms. However, in
the light of the last studies, sperm density could be seen as a
factor of antioxidant consumption.
Another important antioxidant is the lipophilic molecule
Coenzyme Q10 (CoQ), also known as ubiquinone, for its
ubiquitous presence in animals and diﬀerent tissues. It
is a component of the mitochondrial respiratory chain,
therefore potentially involved in spermatozoa function both
for energetic and antioxidant properties. We assayed for the
ﬁrst time CoQ levels both in total seminal ﬂuid and in
seminal plasma (obtained by centrifugation) [28]. In this
original study, conducted on 77 subjects with normal or
pathologicalﬁndingsatastandardsemenanalysis(according
to WHO criteria [29]), CoQ levels, measured by HPLC,
showedasigniﬁcantcorrelationwithspermcountandsperm
motility. However VAR patients represented an interesting
exception; in fact in these patients the correlation with
sperm concentration was preserved, whereas the correlation
with sperm motility was lacking. Moreover, they showed an
increased plasma to total seminal CoQ ratio in comparison
with the other subjects. We suggested a possible molecular
defect in VAR; a relative deﬁciency or a defective utilization
of CoQ in sperm cells could contribute to the respiratory
chaindefectreportedinspermatozoaofthesesubjects,where
ar e d u c t i o ni nO 2 consumption had been showed [30].Advances in Urology 3
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Figure 1: Standard sperm analysis and total antioxidant status
(values are medians; data from [33]).
In a following study, we also determined CoQ in the cell
pelletofspermatozoa,obtainedaftercentrifugationofsemen
[31]. We found, once again, a diﬀerential pattern in VAR and
non-VAR subjects. In non-VAR, a higher concentration of
CoQ (expressed as ng per million of cells) was present in
the spermatozoa of oligo- and asthenozoospermic patients.
This relationship was not observed in VAR, who also
showed slightly lower intracellular absolute values of CoQ.
Since CoQ is involved in the cell defence against free
radical damage, a higher intracellular concentration may
represent a mechanism of protection for spermatozoa. In
VAR patients, this mechanism seems to be defective, leading
to higher sensitivity to oxidative damage. The results were
conﬁrmed in extended groups of patients, compared to
controls,matchedwithVARaccordingtoseminalparameters
(idiopathic oligozoospermia, isolated asthenozoospermia,
normal fertile men) [32]. We remarked the signiﬁcantly
higher proportion of CoQ in seminal plasma; as it reﬂects an
interchange between intra- and extracellular compartments,
the diﬀerent distribution in VAR patients could represent a
greater sensitivity to peroxidative damage and could suggest
its reduced utilization for energy and therefore a defective
motility even in patients with normal sperm count.
More recently, we studied a group of unselected infertile
patients (n = 100; divided into 3 subgroups:VAR, infections,
other etiologies) and 31 fertile men, also correlating Lag
values (TAC) with circulating hormones: gonadotropins,
testosterone, estradiol, fT3, fT4, TSH, and prolactin (PRL)
[33]. We conﬁrmed the ﬁnding of a higher TAC in VAR than
controls, while lower values were in patients with inﬂamma-
tion. The regression analysis between hormones and seminal
parameters showed an inverse correlation between PRL and
sperm motility and a direct correlation of TAC with PRL
or fT4, but not with gonadotropins or gonadal steroids.
Interesting was the suggestion that systemic hormones may
play a role in regulating seminal TAC, even hormones, such
as thyroid ones and prolactin, which are not usually tested
in the ﬁrst-level evaluation of male patients with fertility
problems. Figure 1 shows the main results found in that
study, with respect to TAC diﬀerences in the various groups.
In another study, a multivariate analysis, including
FSH, Lag, percentage of forward-progressive spermatozoa,
oligozoospermia, and VAR, had showed a strong inverse
correlation between FSH and motility (r2 = 0.31, P >
F = 0.0007), not modiﬁed by Lag (r2 = 0.31, P >F=
0.002), suggesting that the link between FSH levels and
sperm motility is probably represented by the length of Lag
phase, suggesting a compensatory role of FSH in modulating
antioxidant systems [34].
3.Effects of SurgicalTreatment
The eﬀect of varicocelectomy on OS, similarly, is not
so univocally clear. Vitamin E has been demonstrated to
be positively aﬀected by surgical VAR repair [35]. The
relationship between varicocelectomy and plasma OS has
been studied also in children (10–16 years) with left-sided
VAR and ipsilateral testicular hypoplasia, by evaluating
basal (presurgery) thiobarbituric acid reactive substances
and plasma peroxidation susceptibility (lag time and slope)
both in peripheral blood samples and in samples from
the pampinous plexus. Peripheral blood samples were re-
evaluated 1 year after surgery. Both parameters were com-
parable in peripheral and pampinous blood and higher
compared with controls. After surgery they signiﬁcantly
decreased, again suggesting that surgical varicocelectomy
with a venous shunt construction reduces OS. The study
highlights that OS is present in children and adolescents with
VAR [36].
Our group also studied VAR patients in an attempt
to verify whether varicocelectomy had an eﬀect on CoQ
distribution in seminal ﬂuid [37]. Only a partial reversion
was observed, since the seminal plasma CoQ/total CoQ ratio
(higher in VAR vs controls) decreased, but the correlation
between total CoQ and motility was not restored; instead,
a peculiar correlation between cellular CoQ and motility
(an inverse correlation, observed at variance with normal
subjects, before surgery) was no longer detectable in post-
operative VAR patients.
4. Effects of Exogenous CoQ Treatment
The ﬁndings mentioned in the previous paragraphs consti-
tute the rationale for treating infertile subjects, particularly
VAR, with exogenous CoQ.
L e w i na n dL a v o n[ 38] originally reported the eﬀect
of CoQ on sperm motility in vitro: a signiﬁcant increase
in motility had been observed in sperm obtained from
asthenozoospermic men, incubated with exogenous CoQ,
whereas no signiﬁcant variation was reported in the motility
of sperm cells from normal subjects. The same study
also reported the eﬀect of exogenous CoQ in vivo, in a
group of patients with low fertilization rates, after in vitro
fertilization with intracytoplasmatic sperm injection for
male factor infertility. No signiﬁcant changes were reported
in most sperm parameters, but a signiﬁcant improvement
was noticed in the fertilization rate after a treatment with
CoQ at the dosage of 60mg/day for a mean period of 103
days.4 Advances in Urology
To investigate a potential therapeutic role, Balercia et
colleagues administered CoQ to a group of 22 idiopathic
asthenozoospermic infertile patients [39], classiﬁed accord-
ing to WHO-1999 criteria [29]. Patients were given CoQ,
200mg/day divided into two doses per os, for 6 months.
Semen analysis, including computer-assisted sperm analysis
and motility (C.A.S.A.), CoQ, and phosphatidylcholine
assays, were performed at baseline and after 6 months
of therapy. A semen analysis was further performed after
6 months from interruption of therapy (wash-out). After
treatment, an increase in CoQ and phosphatidylcholine
concentrations were found both in seminal plasma and in
sperm cells. Regarding semen, a signiﬁcant diﬀerence was
found in forward motility of sperm cells after 6 months
of CoQ oral supplementation. But the main result was the
improvement of sperm motility, also conﬁrmed by means
of computer-assisted determination of kinetic parameters
(signiﬁcantincreaseofVCLandVSL).Apositivedependence
(using the Cramer’s index of association) was evident among
the relative variations of seminal plasma or intracellular
CoQ content and of C.A.S.A. kinetic parameters (Cramer’s
V 1/4 0.4637; 0.3818; 0.3467; 0.5148, resp.). A signiﬁcant
reduction in sperm forward motility was reported after
6 months of washout, whereas no signiﬁcant diﬀerences
were found in sperm cells concentration and morphology.
These results constitute the ﬁrst demonstration that exoge-
nous administration of CoQ increases its levels in seminal
plasma and in spermatozoa. The increment was important,
especially in seminal plasma where posttreatment levels
were three times higher than basal ones. Similar increases
of CoQ concentration (two-threefold higher than baseline
value) are commonly found in blood plasma after chronic
administration of the quinone [40].
As CoQ is a highly lipophylic molecule, we could rea-
sonably hypothesize its diﬀusion through the phospholipid
bilayer of cellular membranes, but we presently do not
know whether transport from blood plasma to testicular and
accessory male genital glands is passive or involves an active
mechanism. Nevertheless, the good degree of association
among these variables, according to Cramer’s V index of
association, supports the hypothesis of a pathogenetic role of
CoQinasthenozoospermia,accordingtopreviouslyreported
data [32]. Apparent improvement of the spontaneous preg-
nancy rate, even though this was not a primary endpoint of
thestudy,alsosuggeststhatthistherapeuticapproachmaybe
beneﬁcial.
These results were conﬁrmed by a double-blind placebo-
controlled clinical trial, realized by the same group [41],
using CoQ dosage similar to that used in the previous
open trial on male infertility. The study design was: 1
month run in, 6 months of therapy (30 patients) or
placebo (30 patients), and a further 3-month followup.
The study conﬁrmed the increase in CoQ levels both in
seminal plasma and sperm cells; also CoQH (the reduced
form of CoQ, with a higher antioxidant eﬃcacy) showed
a similar increase. A signiﬁcant improvement of sperm cell
total motility and forward motility was observed in the
treated group after 6 months of CoQ administration. The
improvement of sperm cell kinetic parameters was also
conﬁrmedaftercomputer-assistedanalysis,withasigniﬁcant
increase both in VCL and VSL after treatment. Moreover,
patientswithlowerbaselinevalueofmotilityandlowerlevels
of CoQ had a statistically signiﬁcant higher probability to
be responders to the treatment. Wash-out data conﬁrmed
the expected treatment-related results. Nine spontaneous
pregnancies were achieved during the observation period.
After opening the randomisation list, it was found that six
of the patients who had impregnated their female partner
had undergone CoQ therapy (three after 4 months, one
after 5 months and one after 6 months of treatment). Three
pregnancies occurred in partners of patients undergoing
placebo treatment: one after 2 months of treatment and the
other 2 after 3 months of washout.
Ap o s i t i v ee ﬀect of CoQ treatment on sperm features
was also conﬁrmed in a study by Safarinejad [42], in which
212 infertile men with idiopathic oligoastenospermia were
treated either with CoQ (300 mg/day) or placebo. Treatment
lasted 26 weeks and was followed by a 30-week washout.
Signiﬁcant improvement in sperm concentration and motil-
ity was found with CoQ therapy for both parameters. The
Kruger classiﬁcation sperm morphology revealed an increase
in the percent of normal forms in the CoQ group. The CoQ
group also showed a signiﬁcant decrease in serum FSH and
LH at 26-week treatment phase. By the end of treatment
phase, percentage of acrosome reaction increased in the CoQ
group whereas it remained unchanged in the placebo group.
Monitoring pregnancy rate was not among the aims of this
study.
Taken together, these studies show an improved sperm
motility upon exogenous CoQ administration, which could
be explained on the basis of the well known involvement of
CoQ in mitochondrial bioenergetics and of its widely recog-
nized antioxidant properties. The increased concentration of
CoQ in seminal plasma and sperm cells, the improvement of
semen kinetic features after treatment, and the evidence of
a direct correlation between CoQ concentrations and sperm
motility strongly support a direct cause/eﬀect relationship.
5. Conclusion
Even if it is clear that Oxidative Stress is present in varicocele
as a pathogenic mechanism, however the interpretation of
analytical data is not so simple. In fact, antioxidants values
can be inﬂuenced by diﬀerent modulatory factors, and
anyway they always represent the balance between synthesis
and utilization.
A deeper insight into these molecular mechanisms could
lead to a greater knowledge of the so-called unexplained
infertility. However, diﬀerent aspects of varicocele phys-
iopathology need to be still investigated, including the age-
relatedeﬀectofoxidativestress,thebiochemicalcomposition
of seminal plasma.
These data are waiting for being integrated with the
novel approaches to infertility studies including genetic
and proteomic investigation, which can further clarify to
what extent varicocele can aﬀect sperm function and which
predictive values we can dispose to better give an indication
to surgical or medical therapy in such a condition.Advances in Urology 5
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